Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Diabetes Care|May 10, 2014
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trialYoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, et al.Diabetologia|May 10, 2020
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE studyKatie Harris, Megumi Oshima, Naveed Sattar, et al.Diabetes|November 14, 2013
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE studyGordon Lowe, Mark Woodward, Graham Hillis, et al.Cardiovascular Diabetology|July 29, 2017
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetesKamel Mohammedi, Mark Woodward, Michel Marre, et al.BMJ Open|January 10, 2016
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trialJuuso I Blomster, Mark Woodward, Sophia Zoungas, et al.Journal of the American College of Cardiology|September 15, 2022
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With DiabetesNelson Wang, Katie Harris, Pavel Hamet, et al.Cardiovascular Diabetology|September 4, 2016
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON studyKamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, et al.Diabetes Care|July 27, 2016
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 DiabetesKamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, et al.Hypertension (Dallas, Tex. : 1979)|June 7, 2017
Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON StudyToshiaki Ohkuma, Mark Woodward, Min Jun, et al.Journal of Hypertension|April 22, 2021
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE TrialsNelson Wang, Katie Harris, John Chalmers, et al.Pageof 8